554 related articles for article (PubMed ID: 1379913)
1. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Lyman CA; Walsh TJ
Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
[TBL] [Abstract][Full Text] [Related]
2. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and clinical impact of antifungal drug resistance.
Vanden Bossche H; Warnock DW; Dupont B; Kerridge D; Sen Gupta S; Improvisi L; Marichal P; Odds FC; Provost F; Ronin O
J Med Vet Mycol; 1994; 32 Suppl 1():189-202. PubMed ID: 7722785
[No Abstract] [Full Text] [Related]
4. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
5. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
6. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
8. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
Supparatpinyo K; Nelson KE; Merz WG; Breslin BJ; Cooper CR; Kamwan C; Sirisanthana T
Antimicrob Agents Chemother; 1993 Nov; 37(11):2407-11. PubMed ID: 8285625
[TBL] [Abstract][Full Text] [Related]
9. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
10. Use of amphotericin B with azole antifungal drugs: what are we doing?
Sugar AM
Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690
[No Abstract] [Full Text] [Related]
11. New antifungal agents.
Graybill JR
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):402-12. PubMed ID: 2546775
[TBL] [Abstract][Full Text] [Related]
12. [The activity of systemic antimycotic drug combinations].
Viudes A; Pemán J; Cantón E; López-Ribot J; Gobernado M
Rev Esp Quimioter; 2001 Mar; 14(1):30-9. PubMed ID: 11376347
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Van Cutsem J
Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
15. Antifungal agents used for deep-seated mycotic infections.
Hermans PE; Keys TF
Mayo Clin Proc; 1983 Apr; 58(4):223-31. PubMed ID: 6339832
[TBL] [Abstract][Full Text] [Related]
16. New antifungal agents for the systemic mycoses.
Ringel SM
Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of resistance to antifungal agents].
Makimura K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
[No Abstract] [Full Text] [Related]
18. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
19. In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Edwards R; Birrell LN; Finch RG
Chemioterapia; 1987 Feb; 6(1):3-7. PubMed ID: 3829134
[TBL] [Abstract][Full Text] [Related]
20. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
